3 Axis Advisors

05/16/2026

“This should be applauded because it obviously addresses what is a fundamental misalignment in the marketplace …

The question again will be: Will it be legitimate? Will it be meaningful?”

UnitedHealth Group's Optum Rx joins rival pharmacy benefit managers by promising greater transparency.

04/30/2026

The Federal Trade Commission's deal with Express Scripts was supposed to help pharmacies. Not so, they say.

03/09/2026

“Hospital pricing remains opaque, and it's possible for the same drug at the same hospital to have a dozen different prices on the same day”

Hospital pricing remains opaque, and the same drug at the same hospital can have a dozen different prices on the same day.

03/07/2026

Same drug, same time … way different prices.

Our latest study unpacks the disparate world of hospital pricing:

In an effort to curb skyrocketing medical debt, the Hospital Price Transparency Rule mandates that U.S. hospitals disclose their "standard charges," yet this comprehensive analysis of over 1,300 facilities reveals a stark divide between technical compliance and actual transparency. While 9

02/12/2026

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and Express Scripts that oversee prescription drug benefits.

02/11/2026

Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA)

01/14/2026

“Because in a system designed around information asymmetry, data is power. And it's time plan sponsors took that power back.”

By Antonio Ciaccia, Co-Founder of 46brooklyn Research and President of 3 Axis AdvisorsAs we close out 2025, it's time to examine what this year revealed about the prescription drug marketplace—and what it means for employers heading into 2026.I recently joined Scripta Insights for a "pharmacy bene...

01/12/2026

“You’re looking at a business model that, in general, is contorting itself to try and make old money in new ways.”

Three mysterious entities. Tens of billions in revenue. CVS, UnitedHealth, and Cigna created "PBM GPO" subsidiaries to divert billions of dollars.

01/01/2026

2026 is off with a bang.

Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively by healthcare research firm 3 Axis Ad...

12/12/2025

Just one change or a sign of things to come?

The drugmaker has about 23,000 employees who will be covered by Rightway.

10/30/2025

Last week, Antonio Ciaccia, Mark Cuban, and Cynthia Fisher spoke to an audience of oncology stakeholders to discuss the importance of healthcare price transparency and ridding the marketplace of its addiction to inflated drug prices.